Avery D H, Osgood T B, Ishiki D M, Wilson L G, Kenny M, Dunner D L
Am J Psychiatry. 1985 Jul;142(7):844-8. doi: 10.1176/ajp.142.7.844.
The authors administered the dexamethasone suppression test (DST) to outpatients, who were free from psychoactive drugs for at least 10 days before the test, with primary affective disorder (N = 60), generalized anxiety disorder (N = 26), panic disorder (N = 22), and agoraphobia with panic attacks (N = 13). With a cortisol value of 5 micrograms/dl considered nonsuppression, there were no significant differences in dexamethasone nonsuppression rates among the diagnostic groups. Scores on the Hamilton Rating Scale for Depression and a melancholia subscale were significantly higher in the depressed group than in the anxiety disorder group. The findings raise questions concerning the specificity of the DST for primary affective disorder in relationship to anxiety disorders.
作者对门诊患者进行了地塞米松抑制试验(DST),这些患者在试验前至少10天未使用精神活性药物,患有原发性情感障碍(N = 60)、广泛性焦虑症(N = 26)、惊恐障碍(N = 22)和伴有惊恐发作的广场恐惧症(N = 13)。以皮质醇值5微克/分升为无抑制标准,各诊断组之间地塞米松无抑制率无显著差异。抑郁症组的汉密尔顿抑郁量表评分和抑郁亚型评分显著高于焦虑症组。这些发现引发了关于DST对原发性情感障碍相对于焦虑症的特异性的疑问。